CN108552451A - Drinks after a kind of movement - Google Patents
Drinks after a kind of movement Download PDFInfo
- Publication number
- CN108552451A CN108552451A CN201810326524.8A CN201810326524A CN108552451A CN 108552451 A CN108552451 A CN 108552451A CN 201810326524 A CN201810326524 A CN 201810326524A CN 108552451 A CN108552451 A CN 108552451A
- Authority
- CN
- China
- Prior art keywords
- ingredient
- amino acid
- collagen
- wheat gluten
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000033001 locomotion Effects 0.000 title claims abstract description 35
- 239000000843 powder Substances 0.000 claims abstract description 64
- 235000001014 amino acid Nutrition 0.000 claims abstract description 50
- 150000001413 amino acids Chemical class 0.000 claims abstract description 50
- 150000005693 branched-chain amino acids Chemical class 0.000 claims abstract description 37
- 239000000126 substance Substances 0.000 claims abstract description 36
- 108010068370 Glutens Proteins 0.000 claims abstract description 35
- 241000209140 Triticum Species 0.000 claims abstract description 35
- 235000021307 Triticum Nutrition 0.000 claims abstract description 35
- 235000021312 gluten Nutrition 0.000 claims abstract description 35
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 30
- 102000008186 Collagen Human genes 0.000 claims abstract description 27
- 108010035532 Collagen Proteins 0.000 claims abstract description 27
- 229920001436 collagen Polymers 0.000 claims abstract description 27
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 claims abstract description 26
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 26
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 26
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 25
- 239000005862 Whey Substances 0.000 claims abstract description 24
- 235000019742 Vitamins premix Nutrition 0.000 claims abstract description 23
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 23
- 239000011707 mineral Substances 0.000 claims abstract description 23
- 239000000203 mixture Substances 0.000 claims abstract description 23
- 235000008939 whole milk Nutrition 0.000 claims abstract description 23
- 244000068988 Glycine max Species 0.000 claims abstract description 21
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 21
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims abstract description 21
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims abstract description 21
- 101710089165 Protein white Proteins 0.000 claims abstract description 21
- 229960002429 proline Drugs 0.000 claims abstract description 21
- 238000000926 separation method Methods 0.000 claims abstract description 21
- 230000003301 hydrolyzing effect Effects 0.000 claims abstract description 15
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims abstract description 14
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229960002591 hydroxyproline Drugs 0.000 claims abstract description 14
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims abstract description 14
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 13
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims abstract description 13
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims abstract description 13
- 229960003080 taurine Drugs 0.000 claims abstract description 13
- -1 oligofructose Chemical compound 0.000 claims abstract description 12
- 229940026510 theanine Drugs 0.000 claims abstract description 12
- 239000004375 Dextrin Substances 0.000 claims abstract description 11
- 229920001353 Dextrin Polymers 0.000 claims abstract description 11
- VDTNNGKXZGSZIP-UHFFFAOYSA-N carbutamide Chemical compound CCCCNC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 VDTNNGKXZGSZIP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000013078 crystal Substances 0.000 claims abstract description 11
- 235000019425 dextrin Nutrition 0.000 claims abstract description 11
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000013922 glutamic acid Nutrition 0.000 claims abstract description 10
- 239000004220 glutamic acid Substances 0.000 claims abstract description 10
- 239000000463 material Substances 0.000 claims abstract description 8
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims abstract description 7
- 229960002989 glutamic acid Drugs 0.000 claims abstract description 7
- 239000004480 active ingredient Substances 0.000 claims abstract description 5
- 229940024606 amino acid Drugs 0.000 claims description 48
- 239000002994 raw material Substances 0.000 claims description 21
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 18
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 18
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 18
- 229960004295 valine Drugs 0.000 claims description 18
- 239000004474 valine Substances 0.000 claims description 18
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 16
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 7
- 229910021529 ammonia Inorganic materials 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 102000009027 Albumins Human genes 0.000 claims description 2
- 108010088751 Albumins Proteins 0.000 claims description 2
- 210000000481 breast Anatomy 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 claims 1
- 239000008267 milk Substances 0.000 claims 1
- 210000004080 milk Anatomy 0.000 claims 1
- 235000010755 mineral Nutrition 0.000 abstract description 17
- 235000014393 valine Nutrition 0.000 abstract description 16
- 235000015097 nutrients Nutrition 0.000 abstract description 10
- 235000005772 leucine Nutrition 0.000 abstract description 6
- 150000008543 L-isoleucines Chemical class 0.000 abstract 1
- 150000002614 leucines Chemical class 0.000 abstract 1
- 150000003680 valines Chemical class 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 description 161
- 230000006870 function Effects 0.000 description 27
- 239000000047 product Substances 0.000 description 18
- 235000013616 tea Nutrition 0.000 description 18
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 14
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 14
- 239000003094 microcapsule Substances 0.000 description 13
- 238000010586 diagram Methods 0.000 description 12
- 239000000945 filler Substances 0.000 description 11
- 102000004420 Creatine Kinase Human genes 0.000 description 9
- 108010042126 Creatine kinase Proteins 0.000 description 9
- 210000003205 muscle Anatomy 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 229960000890 hydrocortisone Drugs 0.000 description 7
- 229960003604 testosterone Drugs 0.000 description 7
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 6
- 235000013361 beverage Nutrition 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 239000011630 iodine Substances 0.000 description 6
- 229910052740 iodine Inorganic materials 0.000 description 6
- 229960000310 isoleucine Drugs 0.000 description 6
- 239000011591 potassium Substances 0.000 description 6
- 229960003975 potassium Drugs 0.000 description 6
- 229910052700 potassium Inorganic materials 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 235000021119 whey protein Nutrition 0.000 description 6
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
- 239000005913 Maltodextrin Substances 0.000 description 5
- 229920002774 Maltodextrin Polymers 0.000 description 5
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 5
- 239000000470 constituent Substances 0.000 description 5
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 5
- 229960003136 leucine Drugs 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 229910052749 magnesium Inorganic materials 0.000 description 5
- 229940035034 maltodextrin Drugs 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 229910052711 selenium Inorganic materials 0.000 description 5
- 239000011669 selenium Substances 0.000 description 5
- 229940091258 selenium supplement Drugs 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical group N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 4
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 4
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 4
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 229960004544 cortisone Drugs 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 230000009183 running Effects 0.000 description 4
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- 102100030840 AT-rich interactive domain-containing protein 4B Human genes 0.000 description 3
- KLYCPFXDDDMZNQ-UHFFFAOYSA-N Benzyne Chemical compound C1=CC#CC=C1 KLYCPFXDDDMZNQ-UHFFFAOYSA-N 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 101000792935 Homo sapiens AT-rich interactive domain-containing protein 4B Proteins 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical group OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229960002737 fructose Drugs 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000003054 hormonal effect Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- WHBHBVVOGNECLV-UHFFFAOYSA-N 11-deoxy-17-hydroxy-corticosterone Natural products O=C1CCC2(C)C3CCC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 WHBHBVVOGNECLV-UHFFFAOYSA-N 0.000 description 2
- ZESRJSPZRDMNHY-YFWFAHHUSA-N 11-deoxycorticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 ZESRJSPZRDMNHY-YFWFAHHUSA-N 0.000 description 2
- WHBHBVVOGNECLV-OBQKJFGGSA-N 11-deoxycortisol Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 WHBHBVVOGNECLV-OBQKJFGGSA-N 0.000 description 2
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 2
- DBPWSSGDRRHUNT-CEGNMAFCSA-N 17α-hydroxyprogesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2 DBPWSSGDRRHUNT-CEGNMAFCSA-N 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 2
- PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 108010077895 Sarcosine Proteins 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 229960003767 alanine Drugs 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 229960002478 aldosterone Drugs 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical group OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229960003473 androstanolone Drugs 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 235000009582 asparagine Nutrition 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 229960002433 cysteine Drugs 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- ZESRJSPZRDMNHY-UHFFFAOYSA-N de-oxy corticosterone Natural products O=C1CCC2(C)C3CCC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 ZESRJSPZRDMNHY-UHFFFAOYSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 235000015177 dried meat Nutrition 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000000969 egg white Anatomy 0.000 description 2
- 229960005309 estradiol Drugs 0.000 description 2
- 229930182833 estradiol Natural products 0.000 description 2
- 229960003399 estrone Drugs 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229960003104 ornithine Drugs 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical group CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 229940043230 sarcosine Drugs 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical group Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- VVJYUAYZJAKGRQ-UHFFFAOYSA-N 1-[4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C(O)C1 VVJYUAYZJAKGRQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- 235000000638 D-biotin Nutrition 0.000 description 1
- 239000011665 D-biotin Substances 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- DATAGRPVKZEWHA-UHFFFAOYSA-N L-gamma-glutamyl-n-ethylamine Natural products CCNC(=O)CCC(N)C(O)=O DATAGRPVKZEWHA-UHFFFAOYSA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 229930182844 L-isoleucine Natural products 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- BZQFBWGGLXLEPQ-UHFFFAOYSA-N O-phosphoryl-L-serine Natural products OC(=O)C(N)COP(O)(O)=O BZQFBWGGLXLEPQ-UHFFFAOYSA-N 0.000 description 1
- CZWCKYRVOZZJNM-UHFFFAOYSA-N Prasterone sodium sulfate Natural products C1C(OS(O)(=O)=O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CC=C21 CZWCKYRVOZZJNM-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003761 Vitamin B9 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- AEMFNILZOJDQLW-QAGGRKNESA-N androst-4-ene-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 AEMFNILZOJDQLW-QAGGRKNESA-N 0.000 description 1
- 229960005471 androstenedione Drugs 0.000 description 1
- AEMFNILZOJDQLW-UHFFFAOYSA-N androstenedione Natural products O=C1CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 AEMFNILZOJDQLW-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229960002719 buserelin Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical group [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 101150024923 da gene Proteins 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- CZWCKYRVOZZJNM-USOAJAOKSA-N dehydroepiandrosterone sulfate Chemical compound C1[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 CZWCKYRVOZZJNM-USOAJAOKSA-N 0.000 description 1
- 229950006137 dexfosfoserine Drugs 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 239000011706 ferric diphosphate Substances 0.000 description 1
- 235000007144 ferric diphosphate Nutrition 0.000 description 1
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical group [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 description 1
- 229940036404 ferric pyrophosphate Drugs 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 125000000627 niacin group Chemical group 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 125000003201 pantothenic acid group Chemical group 0.000 description 1
- BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 229950009829 prasterone sulfate Drugs 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 235000014268 sports nutrition Nutrition 0.000 description 1
- 230000007103 stamina Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019159 vitamin B9 Nutrition 0.000 description 1
- 239000011727 vitamin B9 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical group 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses drinks after a kind of movement.The composition that amino acid is provided in the present invention includes 7 kinds of active ingredients：Hydroxyproline, proline, glutamic acid, theanine, L leucines, L isoleucines and L valines；Quality proportioning is followed successively by：0.2‑1：0.2‑1：2‑5：0.05‑0.3：1‑3：0.5‑1.5：0.5‑1.5.The present invention products material include：Wheat gluten, whole milk powder, hydrolyzing lactoalbumin peptide, PURE WHEY, soybean separation protein white powder, collagen, branched-chain amino acid, Amino Acids in Tea, crystal diabetin, oligofructose, sodium carboxymethylcellulose, resistant dextrin, taurine, vitamin premix and mineral substance premix.Composition or the product can be used for：Prepare the drinks taken after movement；As the drinks taken after movement.The present invention has filled up the blank of the domestic accurate nutrient of limit endurance race.
Description
Technical field
The present invention relates to drinks after a kind of movement.
Background technology
There are all kinds of albumen powders, branched-chain amino acid BCAAs, L-Glutamine, theanine, collagen on the market at present
Extra-nutrition product, but it is confined to a certain or a or two kind of combination, the multiple functions ammonia based on Chinese population data basis mostly
The collaborative research of base acid almost blank.
The prior art works slow because functional component is single.The basic data for especially lacking multigroup of large sample is ground
Study carefully, lack comprehensive data of Chinese, therefore restores class product after designing corresponding endurance exercise and often consider not comprehensively,
And not particular for the exercise recovery class product of specific compatriots' constitution, also without for high intensity endurance exercise race
Accurate nutritional supplement product.
These specific amino acids of hydroxyproline, proline are the nutrients easily lost after strenuous exercise, and on the market
The existing less addition of sports nutrition, is especially applied in limit endurance race.
Invention content
The object of the present invention is to provide drinks after a kind of movement.
Present invention firstly provides a kind of compositions for providing amino acid, including following 7 kinds of active ingredient：Hydroxyl dried meat ammonia
Acid, proline, glutamic acid, theanine, L-Leu, l-Isoleucine and Valine；
The quality proportioning of hydroxyproline, proline, glutamic acid, theanine, L-Leu, l-Isoleucine and Valine
It is followed successively by：0.2-1：0.2-1：2-5：0.05-0.3：1-3：0.5-1.5：0.5-1.5.
The quality proportioning of hydroxyproline, proline, glutamic acid, theanine, L-Leu, l-Isoleucine and Valine
It is followed successively by：0.7：0.9g：3.6g：0.07：2.13：1.12：1.12.
The raw material of the composition includes：Wheat gluten (concretely concentrating wheat gluten), whole milk powder, hydrolyzed whey
Protein peptides, PURE WHEY, soybean separation protein white powder, collagen, branched-chain amino acid (concretely branched-chain amino acid micro-capsule
Powder) and Amino Acids in Tea.
The raw material group of the composition becomes：Wheat gluten (concretely concentrating wheat gluten), whole milk powder, hydrolysis breast
Albumin peptide, PURE WHEY, soybean separation protein white powder, collagen, branched-chain amino acid (concretely branched-chain amino acid micro-capsule
Powder) and Amino Acids in Tea.
It is wheat gluten (concretely concentrating wheat gluten), whole milk powder, hydrolyzing lactoalbumin peptide, PURE WHEY, big
The quality of beans separated protein powder, collagen, branched-chain amino acid (concretely branched-chain amino acid microcapsule powder) and Amino Acids in Tea
Proportioning is followed successively by：6.37：4.5：2.15：1.5：1.5：1.43：2.8：0.28.
The present invention also protects a kind of product, includes the composition of any description above.
The raw material of the product includes：Wheat gluten (concretely concentrating wheat gluten), whole milk powder, hydrolyzed whey egg
White peptide, PURE WHEY, soybean separation protein white powder, collagen, branched-chain amino acid (
The raw material group of the product becomes：Wheat gluten (concretely concentrating wheat gluten), whole milk powder, hydrolyzed whey
Protein peptides, PURE WHEY, soybean separation protein white powder, collagen, branched-chain amino acid (concretely branched-chain amino acid micro-capsule
Powder), Amino Acids in Tea, vitamin premix and mineral substance premix.
It is wheat gluten (concretely concentrating wheat gluten), whole milk powder, hydrolyzing lactoalbumin peptide, PURE WHEY, big
Beans separated protein powder, collagen, branched-chain amino acid (concretely branched-chain amino acid microcapsule powder), Amino Acids in Tea, vitamin
The quality proportioning of premix and mineral substance premix is followed successively by 6.37：4.5：2.15：1.5：1.5：1.43：2.8：0.28：0.13：
0.81。
The raw material of the product includes：Wheat gluten (concretely concentrating wheat gluten), whole milk powder, hydrolyzed whey egg
White peptide, PURE WHEY, soybean separation protein white powder, collagen, branched-chain amino acid (concretely branched-chain amino acid microcapsule powder),
Amino Acids in Tea, crystal diabetin, oligofructose, sodium carboxymethylcellulose, resistant dextrin, taurine, vitamin premix and mine
Substance premix.
The raw material group of the product becomes：Wheat gluten (concretely concentrating wheat gluten), whole milk powder, hydrolyzed whey
Protein peptides, PURE WHEY, soybean separation protein white powder, collagen, branched-chain amino acid (concretely branched-chain amino acid micro-capsule
Powder), Amino Acids in Tea, crystal diabetin, oligofructose, sodium carboxymethylcellulose, resistant dextrin, taurine, vitamin premix
And mineral substance premix.
It is wheat gluten (concretely concentrating wheat gluten), whole milk powder, hydrolyzing lactoalbumin peptide, PURE WHEY, big
Beans separated protein powder, collagen, branched-chain amino acid (concretely branched-chain amino acid microcapsule powder), Amino Acids in Tea, crystallization fruit
Sugar, oligofructose, sodium carboxymethylcellulose, resistant dextrin, taurine, vitamin premix and mineral substance premix quality match
Than being followed successively by 6.37：4.5：2.15：1.5：1.5：1.43：2.8：0.28：5.07：0.9：0.8：1.72：0.04：0.13：0.81.
The present invention also protects a kind of preparation method of product, includes the following steps：
(1) vitamin premix, mineral substance premix, Amino Acids in Tea, taurine, mixing, obtain batch mixing A；
(2) batch mixing A, soybean separation protein white powder, branched-chain amino acid (concretely branched-chain amino acid microcapsule powder), resistance paste
Essence, sodium carboxymethylcellulose, oligofructose, collagen, PURE WHEY, hydrolyzing lactoalbumin peptide, whole milk powder, crystallization fruit
Sugar, wheat gluten (concretely concentrating wheat gluten), mixing, obtain product.
In the preparation method of the product, wheat gluten (concretely concentrating wheat gluten), whole milk powder, hydrolyzed whey
Protein peptides, PURE WHEY, soybean separation protein white powder, collagen, branched-chain amino acid (concretely branched-chain amino acid micro-capsule
Powder), Amino Acids in Tea, crystal diabetin, oligofructose, sodium carboxymethylcellulose, resistant dextrin, taurine, vitamin premix
It is followed successively by 6.37 with the quality proportioning of mineral substance premix：4.5：2.15：1.5：1.5：1.43：2.8：0.28：5.07：0.9：
0.8：1.72：0.04：0.13：0.81.
The product that the method is prepared also belongs to protection scope of the present invention.
The function of any description above product is following (a1) or (a2) or (a3)：
(a1) amino acid is provided；
(a2) drinks taken after movement are prepared；
(a3) as the drinks taken after movement.
Composition or product provided by the invention can be used for field of food and field of health care products.
Composition or product provided by the invention can be used for various dosage forms.For example, solid beverage, liquid beverage, energy glue,
Energy stick (nutrition bar), capsule, tablet etc..
The present invention also protects any description above composition, or, the application of any description above product, for following (b1) or
(b2)：
(b1) drinks taken after movement are prepared；
(b2) as the drinks taken after movement.
The drinks are solid beverage or liquid beverage.When the drinks are solid beverage, it can be reconstituted with water
After drink.
Include following 12 kinds of active ingredient in any description above vitamin premix：Ingredient I -1, ingredient I -2, ingredient I -
3, ingredient I -4, ingredient I -5, ingredient I -6, ingredient I -7, ingredient I -8, ingredient I -9, ingredient I -10, ingredient I -11 and ingredient I -
12；
Ingredient I -1 provides the substance with vitamin A function, and ingredient I -2 provides the substance with vitamin B1 function, at
I -3 is divided to provide the substance with vitamin B2 function, ingredient I -4 provides the substance with vitamin B3 function, the offer of ingredient I -5
Substance with vitamin B5 function, ingredient I -6 provide the substance with vitamin B6 function, and ingredient I -7, which provides, has dimension life
The substance of plain B9 functions, ingredient I -8 provide the substance with vitamin B12 function, and the offer of ingredient I -9 has the function of vitamin C
Substance, ingredient I -10 provide with vitamin D function substance, ingredient I -11 provide with Function of Vitamin-E substance, at
I -12 is divided to provide the substance with biotin function；
Ingredient I -1, ingredient I -2, ingredient I -3, ingredient I -4, ingredient I -5, ingredient I -6, ingredient I -7, ingredient I -8, ingredient
I -9, the proportioning of ingredient I -10, ingredient I -11 and ingredient I -12 is followed successively by 1100-1650 μ g：14.22-21.33mg：7.112-
10.67mg：49.11-73.67mg：17.33-26.00mg：7.112-10.67mg：888.9-1333μg：14.22-21.33μg：
255.5-383.3mg：25.55-38.33μg：49.12-73.68mg：121.12-181.68μg.
Include following 9 kinds of active ingredient in any description above mineral substance premix：Ingredient II -1, ingredient II -2, ingredient
II -3, ingredient II -4, ingredient II -5, ingredient II -6, ingredient II -7, ingredient II -8 and ingredient II -9；
Ingredient II -1 provides sodium element, and ingredient II -2 provides P elements, and ingredient II -3 provides potassium element, and ingredient II -4 provides
Magnesium elements, ingredient II -5 provide calcium constituent, and ingredient II -6 provides ferro element, and ingredient II -7 provides Zn-ef ficiency, and ingredient II -8 provides
Selenium element, ingredient II -9 provide iodine；
By ingredient II -1 provide sodium element, by ingredient II -2 provide P elements, by ingredient II -3 provide potassium element,
By ingredient II -4 provide magnesium elements, by ingredient II -5 provide calcium constituent, by ingredient II -6 provide ferro element, by ingredient
The proportioning of the Zn-ef ficiency of II -7 offer, the selenium element provided by ingredient II -8 and the iodine provided by ingredient II -9 is followed successively by
85.19-127.8mg：40.92-61.39mg：85.18-127.8mg：13.08-19.61mg：35.19-52.78mg：1.2088-
1.8134mg：1.4226-2.134mg：2.208-3.312μg：3.614-5.420μg.
Ingredient I -1, ingredient I -2, ingredient I -3, ingredient I -4, ingredient I -5, ingredient I -6, ingredient I -7, ingredient I -8, ingredient
I -9, the proportioning of ingredient I -10, ingredient I -11 and ingredient I -12 is followed successively by 1375 μ g：17.78mg：8.89mg：61.39mg：
21.67mg：8.89mg：1111μg：17.78μg：319.4mg：31.94μg：61.4mg：151.4μg.
By ingredient II -1 provide sodium element, by ingredient II -2 provide P elements, by ingredient II -3 provide potassium element,
By ingredient II -4 provide magnesium elements, by ingredient II -5 provide calcium constituent, by ingredient II -6 provide ferro element, by ingredient
The proportioning of the Zn-ef ficiency of II -7 offer, the selenium element provided by ingredient II -8 and the iodine provided by ingredient II -9 is followed successively by
106.5mg：51.16mg：106.49mg：16.35mg：43.99mg：1.52mg：1.78mg：2.76μg：4.52μg.
The vitamin premix by ingredient I -1, ingredient I -2, ingredient I -3, ingredient I -4, ingredient I -5, ingredient I -6, at
Divide I -7, ingredient I -8, ingredient I -9, ingredient I -10, ingredient I -11, ingredient I -12 and filler composition.
Ingredient I -1 in per 1g vitamin premixs, ingredient I -2, ingredient I -3, ingredient I -4, ingredient I -5, ingredient I -6, at
Point I -7, the content of ingredient I -8, ingredient I -9, ingredient I -10, ingredient I -11 and ingredient I -12 be followed successively by 1100-1650 μ g,
14.22-21.33mg、7.112-10.67mg、49.11-73.67mg、17.33-26.00mg、7.112-10.67mg、888.9-
1333μg、14.22-21.33μg、255.5-383.3mg、25.55-38.33μg、49.12-73.68mg、121.12-181.68μ
g。
The mineral substance premix is by ingredient II -1, ingredient II -2, ingredient II -3, ingredient II -4, ingredient II -5, ingredient
II -6, ingredient II -7, ingredient II -8, ingredient II -9 and filler composition.
The sodium element that is there is provided by ingredient II -1 in per 1g mineral substance premixes, the P elements provided by ingredient II -2, by
The potassium element for dividing II -3 offer, the magnesium elements provided by ingredient II -4 are carried by the calcium constituent of the offer of ingredient II -5, by ingredient II -6
The ferro element of confession, the Zn-ef ficiency provided by ingredient II -7, the selenium element provided by ingredient II -8 and the iodine provided by ingredient II -9
The content of element be followed successively by 85.19-127.8mg, 40.92-61.39mg, 85.18-127.8mg, 13.08-19.61mg,
35.19-52.78mg、1.2088-1.8134mg、1.4226-2.134mg、2.208-3.312μg、3.614-5.420μg。
Ingredient I -1 in per 1g vitamin premixs, ingredient I -2, ingredient I -3, ingredient I -4, ingredient I -5, ingredient I -6, at
Point I -7, the content of ingredient I -8, ingredient I -9, ingredient I -10, ingredient I -11 and ingredient I -12 be followed successively by 1375 μ g, 17.78mg,
8.89mg、61.39mg、21.67mg、8.89mg、1111μg、17.78μg、319.4mg、31.94μg、61.4mg、151.4μg。
The sodium element that is there is provided by ingredient II -1 in per 1g mineral substance premixes, the P elements provided by ingredient II -2, by
The potassium element for dividing II -3 offer, the magnesium elements provided by ingredient II -4 are carried by the calcium constituent of the offer of ingredient II -5, by ingredient II -6
The ferro element of confession, the Zn-ef ficiency provided by ingredient II -7, the selenium element provided by ingredient II -8 and the iodine provided by ingredient II -9
The content of element is followed successively by 106.5mg, 51.16mg, 106.49mg, 16.35mg, 43.99mg, 1.52mg, 1.78mg, 2.76 μ
g、4.52μg。
The ingredient I -1 is axerophtholum aceticum, and the ingredient I -2 is thiamine hydrochloride, and the ingredient I -3 is riboflavin,
The ingredient I -4 is niacinamide, and the ingredient I -5 is D-VB5 calcium, and the ingredient I -6 is puridoxine hydrochloride, the ingredient I -7
For Vitamin B9, the ingredient I -8 is cyanocobalamin, and the ingredient I -9 is L-AA sodium, and the ingredient I -10 is vitamin
D3, the ingredient I -11 are dl- α-D-α-tocopherol acetate, and the ingredient I -12 is D-Biotin.
The ingredient II -1 be sodium citrate and/or disodium hydrogen phosphate, the ingredient II -2 be disodium hydrogen phosphate, it is described at
Point II -3 is potassium citrate and/or potassium chloride, and the ingredient II -4 is magnesium carbonate, and the ingredient II -5 is calcium carbonate, it is described at
It is ferric pyrophosphate to divide II -6, and the ingredient II -7 is zinc sulfate, and the ingredient II -8 is sodium selenite, and the ingredient II -9 is iodine
Sour potassium.
Composition provided by the invention is based on to the comprehensive multigroup data of human body before and after endurance exercise, by monitoring nutrition
Plain situation of change passes through so that it is determined that functional nutrient and being easy to run off nutrient and concentrates wheat gluten, whole milk powder, hydrolysis
Whey protein peptide, PURE WHEY, soybean separation protein white powder, collagen, branched-chain amino acid microcapsule powder and Amino Acids in Tea are several
The combination of kind of raw-food material, realize branched-chain amino acid BCAAs (valine, leucine, isoleucine), glutamine, theanine,
The accurate supplement of the aminoacid ingredients such as hydroxyproline, proline, quicklys promote the body recovery after endurance exercise.
The achievable effect of drinks is：Inhibit creatine kinase fluctuation, it is different to improve valine, L-Leu, L-
Leucine, proline level can slow down injury gained in sports by drinks after targetedly supplementing movement, be damaged after accelerated motion
The reparation of wound.Composition maximum feature provided by the invention is to be based on multigroup data, integrally the element that supplements the nutrients comprehensively, to
Combination of the effect better than single or individual nutrients.
The present invention has filled up the blank of the domestic accurate nutrient of limit endurance race.
Description of the drawings
Fig. 1 is that amino acid is averaged stability bandwidth.
Fig. 2 is that hormone is averaged stability bandwidth.
Fig. 3 is creatine kinase variation diagram in different time points.
Fig. 4 is the horizontal variation diagram of subject's different time points creatine kinase.
Fig. 5 is subject's different time points valine levels variation diagram.
Fig. 6 is the horizontal variation diagram of subject's different time points l-Isoleucine.
Fig. 7 is the horizontal variation diagram of subject's different time points L-Leu.
Fig. 8 is subject's different time points proline level variation diagram.
Specific implementation mode
Embodiment below facilitates a better understanding of the present invention, but does not limit the present invention.Experiment in following embodiments
Method is unless otherwise specified conventional method.Test material as used in the following examples is unless otherwise specified certainly
What routine biochemistry reagent shop was commercially available.Quantitative test in following embodiment is respectively provided with three repeated experiments, as a result makes even
Mean value.The content of each amino acid is detected using the assay method of amino acid in food in GB/T 5009.124-2003.Tea ammonia
Sour (L-Theanine) is distinctive free amino acid in tealeaves, is glutamic acid gamma-buserelin.Using GB/T 8314-2013
Theanine content in the assay method detection Amino Acids in Tea of middle tea free amino acid total amount.Maltodextrin：Western king's sugar industry has
Limit company.
Concentration wheat gluten in embodiment is SYRAL wheat glutens, Shanghai victory at,500, http://
Www.jebsenindustrial.com/%E5%85%B3%E4%BA%8E%E6%88%91%E4% BB%AC/%
E5%90%88%E4%BD%9C%E4%BC%99%E4%BC%B4/syral/syral%E5%B0%8F %E9%
BA%A6%E8%9B%8B%E7%99%BD/.
Whole milk powder used in embodiment is permanent natural whole milk powder, article No. 113120.
Hydrolyzing lactoalbumin peptide used in embodiment isAbundant power peptide：Royal DSM, article No. 5007143.
PURE WHEY used in embodiment is HILMAR8010 concentrated whey protein powders.
Soybean separation protein white powder used in embodiment is 787 soybean separation protein white powders of Du Pont SUPRO.
Collagen used in embodiment is Isin glue collagen peptide：Shanghai system garden health care science and technology, article No. GBB-50SP
757。
Branched-chain amino acid microcapsule powder used in embodiment：Dalian Yi Nuo Biological Co., Ltd., article No. 60102-P.
Amino Acids in Tea used in embodiment be natural tea amino acid (Shanghai promise moral biology is Industrial Co., Ltd.,
TeanovaTM L20 natural teas amino acid), network address http://www.novanat.com/showProduct.asplag
=c＆id=80.
The formula research and development of drinks after embodiment 1, movement
One, it is formulated R＆D process
800 drift sand limit races are first the uninterrupted of extra long distance of China, auto-navigation, from heavy burden cross-country race race；Pole
Limit test：High load capacity motion state, extra long distance, bad environments are changeable；It feeds limited, rest to lack, tests sportsman's physiology
Function.Hua Da movement as mechanism under Hua Da gene, for sportsman provide pre-games, games and post-games, post-games two weeks it is comprehensive
Detection service.It assesses, and provides from gene, metabolism, physiology of exercise, psychology, the mass motion health of sportsman etc.
Personalized recommendations, the exercise program to formulate more science provide foundation.
Amino acid stability bandwidth=(post-games level-pre-games is horizontal)/pre-games level × 100%.The amino acid stability bandwidth that is averaged is shown in
Fig. 1, negative value are horizontal reduction, and positive value increases to be horizontal.In Fig. 1, be followed successively by from left to right hydroxyproline, proline, ornithine,
Valine, alanine, sarcosine, cysteine, isoleucine, leucine, phosphoserine, citrulling, glycine, Soviet Union's ammonia
Acid, γ-oxylysine, lysine, serine, tryptophan, alpha-amido n-butyric acie, asparagine.The average wave of hydroxyproline
It is the average stability bandwidth of -47%, ornithine is being averaged for -44%, valine that dynamic rate, which is the average stability bandwidth of -54%, proline,
It is the average stability bandwidth of -38%, sarcosine is -32%, cysteine that stability bandwidth, which is the average stability bandwidth of -39%, alanine,
It is -24%, phosphoric acid that averagely stability bandwidth, which is the average stability bandwidth that the average stability bandwidth of -30%, isoleucine is -24%, leucine,
The average stability bandwidth of serine be -22%, citrulling average stability bandwidth be -22%, glycine average stability bandwidth be -
22%, the average stability bandwidth of threonine is -20%, the average stability bandwidth of γ-oxylysine is being averaged for -17%, lysine
Stability bandwidth be -11%, serine average stability bandwidth be -9.3%, tryptophan average stability bandwidth be -7.5%, alpha-amido just
The average stability bandwidth of butyric acid is that the average stability bandwidth of -6.4%, asparagine is -4.7%.3 kinds of branched-chain amino acids of sportsman
(BCAA) (valine, isoleucine, leucine) is lost in more：The loss ratio of these three amino acid is 24%-40%.Branch
The loss of amino acid BCAAs accelerates muscle breakdown process, generates stronger sports fatigue sense, and locomitivity declines.Movement
Member's maximum two kinds of amino acid of turnover rate is hydroxyproline and proline.Contain a high proportion of hydroxyproline, dried meat in collagen
Propylhomoserin, and these specific amino acids are the nutrients easily lost after strenuous exercise.Collagen not only individual generation,
It plays an important role as other connective tissues in differentiation and forming process, and has pole with the aging of body and disease
Its close relationship.
Hormonal fluctuations rate=(post-games level-pre-games is horizontal)/pre-games level × 100%.The hormone stability bandwidth that is averaged is shown in Fig. 2,
Negative value is to reduce, and positive value is raising.In Fig. 2, it is followed successively by testosterone/cortisol, testosterone, 17-OH progesterone, progesterone, hero from left to right
Alkene diketone, dehydrobenzene, 11-deoxycorticosterone, cortisone, Compd S 11-deoxycortisol, estradiol, aldosterone, dihydrotestosterone,
Dehydroepiandrosterone sulfate, cortisol, oestrone, cortisone.The average stability bandwidth of testosterone/cortisol is -75%, the average wave of testosterone
Dynamic rate is -63%, and the average stability bandwidth of 17-OH progesterone is -47%, and the average stability bandwidth of progesterone is -40%, and androstenedione is put down
Equal stability bandwidth is -38%, and the average stability bandwidth of dehydrobenzene is -12%, and the average stability bandwidth of 11-deoxycorticosterone is
3.33%, the average stability bandwidth of cortisone is 3.86%, and the average stability bandwidth of Compd S 11-deoxycortisol is 16.4%, estradiol
Average stability bandwidth is 58.7%, the average stability bandwidth of aldosterone is 69.6%, and the average stability bandwidth of dihydrotestosterone is 91.6%, sulphur
The average stability bandwidth of sour dehydrobenzene is 107%, and the average stability bandwidth of cortisol is 126%, and the average stability bandwidth of oestrone is
165%, the average stability bandwidth of cortisone is 230%.Testosterone：It is lost in, muscle mass is accelerated.Cortisol：It increases, sports fatigue increases
Add, carbohydrate, fat, breaks down proteins are accelerated.Testosterone/Cortisol Ratio：Attenuating amplitude is more than 30%, and sportsman belongs on the whole
Excessive movement.
Four kinds of creatine kinase, lactic dehydrogenase, aspartate aminotransferase, alanine aminotransferase muscle metabolism enzymes
It can be used for evaluating muscle damage degree.Variation diagram is shown in Fig. 3 to creatine kinase in different time points.In Fig. 3, time point 1 is match
Before beginning, time point 2 is (the 6th supply point) after match starts 2 days, and time point 3 is after end of match, time point 4 is that match is tied
After beam 2 weeks.Four kinds of muscle enzymic change trend are close：Pre-games is normal；RP6 points (the 6th supply point) rise to peak in match；Match
Declined afterwards, is not restored to normal level；Post-games continues to decline for two weeks, but does not restore still to pre-games normal level.Eight
The match of the hundred drift sand limit has a degree of damage, post-games or even post-games not to restore within two weeks normal to pre-games still sportsman's muscle
It is horizontal.
By being continued to monitor to pre-games, games and post-games different phase sportsman, it is found that sportsman's amino acid levels are lost in
Rate is larger, especially branched-chain amino acid, proline, hydroxyproline.Hormonal readiness (testosterone/Cortisol Ratio) lowers amplitude simultaneously
More than 30%, reflect that prolonged endurance exercise has apparent negative effect to the body of sportsman, and restore slower.Cause
The nutritional support of this corresponding pre-games, games and post-games is very important a link, targetedly supplements corresponding amino
Acid, the relevant hormonal readiness of adjusting can improve the ontology comfort level of sportsman, accelerate the reparation of body items function.
Two, it is formulated core design
Formula core design is shown in Table 1.
Table 1
| Ingredient names | Quality proportioning | Daily design flow |
| Hydroxyproline | 0.2-1 | 0.2-1g |
| Proline | 0.2-1 | 0.2-1g |
| Glutamic acid | 2-5 | 2-5g |
| Theanine | 0.05-0.3 | 0.05-0.3g |
| L-Leu | 1-3 | 1-3g |
| L-Isoleucine | 0.5-1.5 | 0.5-1.5g |
| Valine | 0.5-1.5 | 0.5-1.5g |
Embodiment 2, premix preparation
One, vitamin premix
Vitamin premix is made of function raw material and filler.Filler is maltodextrin.Per 1g vitamin premixs
In the content of each function raw material be shown in Table 2.
Table 2
Vitamin premix for embodiment 3 is made of function raw material and filler.Filler is maltodextrin.Unit
The content of each function raw material is shown in Table 3 in the vitamin premix of quality.
Table 3
Two, mineral substance premix
Mineral substance premix is made of function raw material and filler.Filler is maltodextrin.Per 1g mineral substance premixes
In each function raw material composition and the amount of corresponding function element that provides of each function raw material be shown in Table 4.
Table 4
Mineral substance premix for embodiment 3 is made of function raw material and filler.Filler is maltodextrin.Unit
The content of each function raw material is shown in Table 5 in the mineral substance premix of quality.
Table 5
The preparation (solid beverage) of drinks after embodiment 3, movement
Drinks are 1 people, 1 gift after every 1 bag of movement, and drinks are 30g after every 1 bag of movement.Drinks after movement
Raw material composition, per 30g after movement in drinks the raw material dosage (g), per 30g after movement in drinks by the raw material
The nutrient amount (g) of offer is shown in Table 6.
Table 6
Crystal diabetin：BaoLingBao Biology Co., Ltd, article No. QR0256.Oligofructose：SENSUS, article No.
513E801602.Sodium carboxymethylcellulose：Changzhou state space environmental protection science and technology, article No. FH6.Resistant dextrin：Ba Weita (Shanghai) quotient
Trade Co., Ltd, article No. 338111W.Taurine：The long-range Life Science and Technology Co., Ltd in Hubei, article No. C002-
M1710621。
Crystal diabetin is as energy extender and sweetener.
Oligofructose is as sweetener and enteron aisle buffer.
Sodium carboxymethylcellulose is as adhesive.
Resistant dextrin is as filler.
Taurine is as basic nutrient prime replenisher.
Preparation flow is as follows：
1, vitamin premix, mineral substance premix, Amino Acids in Tea, taurine, are sufficiently mixed, and obtain batch mixing A.
2, batch mixing A, soybean separation protein white powder, branched-chain amino acid microcapsule powder, resistant dextrin, sodium carboxymethylcellulose, oligomeric
Fructose, collagen, PURE WHEY, hydrolyzing lactoalbumin peptide, whole milk powder, crystal diabetin, concentration wheat gluten, it is fully mixed
It closes, obtains mixed material B.
3, mixed material B is dispensed, every bag of 30g.
After testing, after being moved per 30g in drinks, the content of glutamic acid is 3.6g, and the content of proline is 0.9g, hydroxyl
The content of proline is 0.7g, and the content of L-Leu is 2.13g, and the content of l-Isoleucine is 1.12g, and Valine contains
Amount is 1.12g, and the content of theanine is 0.07g.
The compliance test result of drinks after embodiment 4, movement
Using random, parallel control clinical test methods, by 60 running athletes (being the volunteer of informed consent)
It is randomly divided into two groups, every group 30.
Experimental group (per as follows per capita)：
It tests the 0th day evening 8 points (time1), acquires venous blood；
It tests the 1st day to the 4th day：Every morning carries out 20 kilometers of long-distance runnings (running speed control at 10km/ hours), 1 after running
Hour takes drinks (being taken after being reconstituted with boiling water) after movement prepared by one bag of embodiment 3；
It tests the 1st day evening 8 points (time1), the 4th day evening of experiment 8 points (time3), the 7th day evening of experiment 8 points (time4), examination
It tests the 14th day evening (time5) at 8 points, acquires venous blood respectively.
Control group does not take drinks after movement prepared by embodiment 3, other same experimental groups.
The major function of branched-chain amino acid (valine, leucine, isoleucine)：Improve locomitivity, delay fatigue.Branch
Chain amino acid is 3 kinds in 8 kinds of amino acid necessary to body of general name, is the essential nutrient of muscle, accounts for constituting muscle
Amino acid in 30%-40%.The function of branched-chain amino acid：It is in close relations with Human Stamina, can be prolonged
Endurance exercise provides energy reserve；Promote the synthesis of muscle protein；Antidecomposition acts on, and helps to prevent protein breakdown and muscle
It loses, helps to protect muscle；The periphery mechanism for causing exercise induced fatigue is adjusted, the appearance of exercise induced fatigue is postponed；After movement
Supplement branched-chain amino acid can also promote the recovery of exercise induced fatigue.
Measure creatine kinase (CK), valine, L-Leu, the different bright ammonia of L- in the venous blood blood plasma of 5 time points acquisition
The level of acid, proline, assesses its injury gained in sports degree.
The horizontal variation diagram of subject's different time points creatine kinase is shown in Fig. 4 (ordinate unit is U/L).When subject's difference
Between point valine levels variation diagram see Fig. 5 (ordinate unit be μm ol/L).Subject's different time points l-Isoleucine is horizontal
Variation diagram is shown in Fig. 6 (ordinate unit is μm ol/L).The horizontal variation diagram of subject's different time points L-Leu is shown in that Fig. 7 is (vertical to sit
Mark unit is μm ol/L).Subject's different time points proline level variation diagram is shown in Fig. 8 (ordinate unit is μm ol/L).With
Experimental group is compared, and the creatine kinase level of control group has the fluctuation of bigger, valine, L-Leu, l-Isoleucine, proline
It is horizontal lower.The result shows that movement damage can be slowed down by drinks after targetedly supplementing the movement of the preparation of embodiment 3
Wound, the reparation damaged after accelerated motion.
Embodiment 5,
In experimental group, composition shown in volunteer's table 7 (table 7 is 1 day person-portion) is given once daily, is drunk instead of function after movement
Material, other are the same as embodiment 4.Effect is with embodiment 4 without significant difference.
Table 7
Claims (10)
1. a kind of composition for providing amino acid, including following 7 kinds of active ingredient：Hydroxyproline, proline, glutamic acid,
Theanine, L-Leu, l-Isoleucine and Valine；
Hydroxyproline, proline, glutamic acid, theanine, L-Leu, l-Isoleucine and Valine quality proportioning successively
For：0.2-1：0.2-1：2-5：0.05-0.3：1-3：0.5-1.5：0.5-1.5.
2. composition as described in claim 1, it is characterised in that：The bright ammonia of hydroxyproline, proline, glutamic acid, theanine, L-
The quality proportioning of acid, l-Isoleucine and Valine is followed successively by：0.7：0.9g：3.6g：0.07：2.13：1.12：1.12.
3. composition as claimed in claim 1 or 2, it is characterised in that：The raw material of the composition includes：It is wheat gluten, complete
Fat milk powder, hydrolyzing lactoalbumin peptide, PURE WHEY, soybean separation protein white powder, collagen, branched-chain amino acid and tealeaves amino
Acid.
4. composition as claimed in claim 3, it is characterised in that：Wheat gluten, whole milk powder, hydrolyzing lactoalbumin peptide, breast
Albumin powder, soybean separation protein white powder, collagen, branched-chain amino acid and Amino Acids in Tea quality proportioning be followed successively by：6.37：
4.5：2.15：1.5：1.5：1.43：2.8：0.28.
5. a kind of product, including any composition in Claims 1-4.
6. product as claimed in claim 5, it is characterised in that：
The raw material of the product includes：Wheat gluten, whole milk powder, hydrolyzing lactoalbumin peptide, PURE WHEY, soybean separation protein
White powder, collagen, branched-chain amino acid, Amino Acids in Tea, vitamin premix and mineral substance premix；
Wheat gluten, whole milk powder, hydrolyzing lactoalbumin peptide, PURE WHEY, soybean separation protein white powder, collagen, branch
Amino acid, Amino Acids in Tea, vitamin premix and mineral substance premix quality proportioning be followed successively by 6.37：4.5：2.15：
1.5：1.5：1.43：2.8：0.28：0.13：0.81.
7. product as claimed in claim 5, it is characterised in that：
The raw material of the product includes：Wheat gluten, whole milk powder, hydrolyzing lactoalbumin peptide, PURE WHEY, soybean separation protein
White powder, collagen, branched-chain amino acid, Amino Acids in Tea, crystal diabetin, oligofructose, sodium carboxymethylcellulose, resistance paste
Essence, taurine, vitamin premix and mineral substance premix；
Wheat gluten, whole milk powder, hydrolyzing lactoalbumin peptide, PURE WHEY, soybean separation protein white powder, collagen, branch
Amino acid, Amino Acids in Tea, crystal diabetin, oligofructose, sodium carboxymethylcellulose, resistant dextrin, taurine, vitamin premix
The quality proportioning of material and mineral substance premix is followed successively by 6.37：4.5：2.15：1.5：1.5：1.43：2.8：0.28：5.07：0.9：
0.8：1.72：0.04：0.13：0.81.
8. a kind of preparation method of product, includes the following steps：
(1) vitamin premix, mineral substance premix, Amino Acids in Tea, taurine, mixing, obtain batch mixing A；
(2) batch mixing A, soybean separation protein white powder, branched-chain amino acid, resistant dextrin, sodium carboxymethylcellulose, oligofructose, collagen
Albumen, PURE WHEY, hydrolyzing lactoalbumin peptide, whole milk powder, crystal diabetin, wheat gluten, mixing, obtain product；
Wheat gluten, whole milk powder, hydrolyzing lactoalbumin peptide, PURE WHEY, soybean separation protein white powder, collagen, branch
Amino acid, Amino Acids in Tea, crystal diabetin, oligofructose, sodium carboxymethylcellulose, resistant dextrin, taurine, vitamin premix
The quality proportioning of material and mineral substance premix is followed successively by 6.37：4.5：2.15：1.5：1.5：1.43：2.8：0.28：5.07：0.9：
0.8：1.72：0.04：0.13：0.81.
9. the product that claim 8 the method is prepared.
10. any composition in Claims 1-4, or, any product in claim 5 to 7, or, claim
The application of 9 products, for following (b1) or (b2)：
(b1) drinks taken after movement are prepared；
(b2) as the drinks taken after movement.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810326524.8A CN108552451B (en) | 2018-04-12 | 2018-04-12 | Functional beverage after sports |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810326524.8A CN108552451B (en) | 2018-04-12 | 2018-04-12 | Functional beverage after sports |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN108552451A true CN108552451A (en) | 2018-09-21 |
| CN108552451B CN108552451B (en) | 2021-07-27 |
Family
ID=63534816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810326524.8A Active CN108552451B (en) | 2018-04-12 | 2018-04-12 | Functional beverage after sports |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108552451B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111820351A (en) * | 2020-07-23 | 2020-10-27 | 北京冠力体育科技有限公司 | Formula of compound whey protein solid beverage |
| CN113080355A (en) * | 2021-04-23 | 2021-07-09 | 江苏金维氨生物工程有限公司 | Amino acid solid beverage capable of rapidly supplementing nutrition and production process thereof |
| CN114223820A (en) * | 2021-12-28 | 2022-03-25 | 宣城柏维力生物工程有限公司 | Branched chain amino acid beverage for improving muscle content and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1586332A (en) * | 2004-07-02 | 2005-03-02 | 杭州娃哈哈集团有限公司 | Functional sport drink and its preparing method |
| CN105661235A (en) * | 2016-01-22 | 2016-06-15 | 江苏艾兰得营养品有限公司 | Beverage for supplementing compound nutrients and production method thereof |
| CN106259946A (en) * | 2016-08-23 | 2017-01-04 | 江苏朸健生命科技发展有限公司 | A kind of sport nutrition solid beverage and preparation method thereof |
| CN106617086A (en) * | 2016-12-30 | 2017-05-10 | 贝克尔（天津）药业有限公司 | Nutritional food capable of enhancing exercise capacity and exercise tolerance |
| CN106720373A (en) * | 2016-12-02 | 2017-05-31 | 南通励成生物工程有限公司 | A kind of anti-fatigue solid beverage and preparation method thereof |
-
2018
- 2018-04-12 CN CN201810326524.8A patent/CN108552451B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1586332A (en) * | 2004-07-02 | 2005-03-02 | 杭州娃哈哈集团有限公司 | Functional sport drink and its preparing method |
| CN105661235A (en) * | 2016-01-22 | 2016-06-15 | 江苏艾兰得营养品有限公司 | Beverage for supplementing compound nutrients and production method thereof |
| CN106259946A (en) * | 2016-08-23 | 2017-01-04 | 江苏朸健生命科技发展有限公司 | A kind of sport nutrition solid beverage and preparation method thereof |
| CN106720373A (en) * | 2016-12-02 | 2017-05-31 | 南通励成生物工程有限公司 | A kind of anti-fatigue solid beverage and preparation method thereof |
| CN106617086A (en) * | 2016-12-30 | 2017-05-10 | 贝克尔（天津）药业有限公司 | Nutritional food capable of enhancing exercise capacity and exercise tolerance |
Non-Patent Citations (3)
| Title |
|---|
| 周雪冬: "茶氨酸的生理作用研究及与运动的影响关系", 《福建茶业》 * |
| 蔡威: "《食物营养学》", 30 September 2006, 上海交通大学出版社 * |
| 袁运平: "《短跑运动员体能训练理论与方法》", 31 August 2006, 北京体育大学出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111820351A (en) * | 2020-07-23 | 2020-10-27 | 北京冠力体育科技有限公司 | Formula of compound whey protein solid beverage |
| CN113080355A (en) * | 2021-04-23 | 2021-07-09 | 江苏金维氨生物工程有限公司 | Amino acid solid beverage capable of rapidly supplementing nutrition and production process thereof |
| CN114223820A (en) * | 2021-12-28 | 2022-03-25 | 宣城柏维力生物工程有限公司 | Branched chain amino acid beverage for improving muscle content and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN108552451B (en) | 2021-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108552451A (en) | Drinks after a kind of movement | |
| Gleeson | Dosing and efficacy of glutamine supplementation in human exercise and sport training | |
| US10045999B2 (en) | Nutritional composition for the stimulation of muscle protein synthesis | |
| EP1983849B1 (en) | A food composition comprising amino acids | |
| CA2399500A1 (en) | Alpha lipoic acid based food supplement for increasing lean muscle mass and strength | |
| CN1321589C (en) | Soy-bean peptide | |
| CA2537647A1 (en) | Supplemental dietary composition for supporting muscle growth, recovery and strength | |
| CN105558744B (en) | A kind of effervescent tablet and preparation method thereof containing branched-chain amino acid | |
| MXPA02003861A (en) | Food supplement for increasing lean mass and strength. | |
| CN1364430A (en) | Method for storaging acid liquid or semiliquid composition containing kreatin for human consumption | |
| KR20020062927A (en) | Food supplement for increasing lean mass and strength | |
| US20140356479A1 (en) | Compositions and methods for use in promoting lean body mass | |
| WO2005084440A8 (en) | Method for increasing muscle mass and strength through administration of adenosine triphosphate | |
| US20180042879A1 (en) | Free amino acid preparation and uses thereof | |
| CN108684999A (en) | A kind of motor function beverage | |
| WO2007063297A1 (en) | Improvements in and relating to nutritional products | |
| GB2504390A (en) | Composition comprising selenium, vitamin C and whey protein | |
| CN104824660A (en) | Collagen-saussurea involucrata small peptide effervescent tablet and preparation method thereof | |
| Jordan et al. | Ergogenic aids and the female athlete | |
| Petkova et al. | Essential amino acids-review of some of the contemporary analytical methods for detection | |
| CN114096159A (en) | Vegetable protein mixture and nutritional composition | |
| EP2745710A1 (en) | A nutraceutical compound | |
| JP2003061631A (en) | Powder beverage and food mainly comprising citric acid and amino acid | |
| AU2011346315B2 (en) | Method of intensifying the physiological action of caffeine | |
| JP6397818B2 (en) | Method for improving photostability of food and drink |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |